Radcliffe Capital Management, L.P. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$672,317
+1.7%
66,566
-0.2%
0.02%
+31.2%
Q3 2022$661,000
+1.2%
66,6660.0%0.02%
+6.7%
Q2 2022$653,000
+0.3%
66,6660.0%0.02%0.0%
Q1 2022$651,000
+0.6%
66,6660.0%0.02%
-11.8%
Q4 2021$647,000
-0.3%
66,6660.0%0.02%
-10.5%
Q3 2021$649,000
+0.3%
66,6660.0%0.02%
-5.0%
Q2 2021$647,00066,6660.02%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 66,666$651,0000.02%
DIFESA CAPITAL MANAGEMENT, LP 14,159$3,0000.00%
MARSHALL WACE, LLP 108,584$1,065,0000.00%
Arena Capital Advisors, LLC- CA 69,251$14,0000.00%
Dryden Capital, LLC 15,000$3,0000.00%
PICTON MAHONEY ASSET MANAGEMENT 91,665$19,0000.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 100,000$20,0000.00%
PERISCOPE CAPITAL INC. 154,800$31,0000.00%
MMCAP International Inc. SPC 73,525$15,0000.00%
GABELLI & Co INVESTMENT ADVISERS, INC. 21,896$4,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders